Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Leth

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Frontiers in Microbiology|January 23, 2023
Structure and metabolic potential of the prokaryotic communities from the hydrothermal system of Paleochori Bay, Milos, GreeceSven Le Moine Bauer, Guang-Sin Lu, Steven Goulaouic, et al.
The Lancet. HIV|September 24, 2016
Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trialSteffen Leth, Mariane H Schleimann, Sara K Nissen, et al.
Plos Pathogens|September 18, 2015
The Depsipeptide Romidepsin Reverses HIV-1 Latency In VivoOle S Søgaard, Mette E Graversen, Steffen Leth, et al.
Clinical and Experimental Immunology|April 10, 2026
Immunological Dysfunction Associated with SARS-CoV-2 Persistence in Immunocompromised PatientsIda M Johannsen, Line K Vibholm, Giacomo S Frattari, et al.
Clinical Epidemiology|June 12, 2026
The Danish Database for Hepatitis B and C (DANHEP): A Nationwide, Prospective, Ongoing Cohort StudySigne Bollerup, Christina Sølund, Sofie Hallager, et al.
Nature Medicine|September 11, 2023
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trialJesper D Gunst, Jesper F Højen, Marie H Pahus, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Frontiers in Microbiology|January 23, 2023
Structure and metabolic potential of the prokaryotic communities from the hydrothermal system of Paleochori Bay, Milos, GreeceSven Le Moine Bauer, Guang-Sin Lu, Steven Goulaouic, et al.
The Lancet. HIV|September 24, 2016
Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trialSteffen Leth, Mariane H Schleimann, Sara K Nissen, et al.
Plos Pathogens|September 18, 2015
The Depsipeptide Romidepsin Reverses HIV-1 Latency In VivoOle S Søgaard, Mette E Graversen, Steffen Leth, et al.
Clinical and Experimental Immunology|April 10, 2026
Immunological Dysfunction Associated with SARS-CoV-2 Persistence in Immunocompromised PatientsIda M Johannsen, Line K Vibholm, Giacomo S Frattari, et al.
Clinical Epidemiology|June 12, 2026
The Danish Database for Hepatitis B and C (DANHEP): A Nationwide, Prospective, Ongoing Cohort StudySigne Bollerup, Christina Sølund, Sofie Hallager, et al.
Nature Medicine|September 11, 2023
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trialJesper D Gunst, Jesper F Højen, Marie H Pahus, et al.
Pageof 6